Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Bernheim, Dreyfus & Co. launching new Ucits M&A Fund

Monday, June 06, 2011
Opalesque Industry Update - Bernheim Dreyfus, the Paris-based investment manager, launched last week a mergers and acquisitions fund regulated under UCITS III rules to meet increased investor demands for more liquid and transparent investments in this sector of market activity.

The Diva Synergy (Ucits) fund is regulated by the French Financial Authority (Autorité des marchés financiers) and replicates the event-driven Diva Synergy Fund which gained over 27% last year successfully exploiting the increase in M&A activity during 2010.

Amit Shabi, partner at Bernheim Dreyfus, expects the volume of M&A activity will continue to rise through 2011 creating an exceptional range of investment opportunities. ‘M&A picked up momentum in 2010 and continues to grow rapidly. We’re forecasting global deal activity to increase by as much as 40% this year, by comparison to 2010’’.

The Diva Synergy (Ucits) fund started investing in June 1st and has initial committed capital of $10mln. The target is to manage $100mln within 1 year.

Explaining the decision to launch a UCITS product Shabi said, ‘’During the financial crisis it became clear that many hedge funds were not in line with investors’ expectations in terms of liquidity and transparency. The Diva Synergy (Ucits) fund will offer transparency and liquidity as we respond to investor requirements for products which conform with the EU Directive.’’.

(press release)

Bernheim, Dreyfus & Co.

Paris-based Bernheim, Dreyfus & Co was founded in 2006 as an alternative investment firm focusing on M&A-related strategies, managing an event driven hedge fund – Diva Synergy.

Diva Synergy is managed by Amit Shabi and Lionel Melka. Lionel Melka has 10 years’ of experience as an M&A advisor for blue chip clients in prestigious banks as Lazards, Calyon and Rothschilds. He has been involved in more than 20 major transactions totaling more than $50 billion.

Amit Shabi has long experience in asset management and capital markets with Rothschilds, the Man Group and others.Corporate website: Source
KM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for